Spirecut
Developing surgical instruments that do not require a skin incision, stitches, or dressing.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | N/A | Series A |
| Total Funding | 000k | ||
Related Content
Spirecut SA, a Swiss medical technology company established in 2020, is focused on advancing minimally invasive surgical procedures for common hand ailments. The company was founded by Professor Frédéric Schuind, who also serves as the CEO, leveraging his expertise to develop less invasive treatments for conditions like carpal tunnel syndrome and trigger finger.
The core of Spirecut's business is its patented Sono-Instruments®, a set of devices designed for ultrasound-guided, percutaneous surgery. This technique, called SonoSurgery, allows surgeons to perform procedures through a skin puncture as small as 1 millimeter, guided by real-time ultrasound imaging. This approach eliminates the need for larger incisions and sutures, significantly reducing recovery time and avoiding visible scarring, which allows patients to resume daily activities almost immediately. The company's product line includes specific tools for carpal tunnel syndrome and trigger finger, a sterile liquid immersion system (Sono-Bath®) for improved ultrasound clarity, and an all-in-one sterile procedural kit (Sono-Pack®).
Spirecut operates on a business-to-business model, selling its FDA-cleared and CE-marked instruments to healthcare providers and clinics through a global network of distributors. Revenue is generated from the sale of these surgical instruments and related products. To drive adoption and ensure high standards, the company has established Centers of Excellence, such as the one at Clinique de la Main in Geneva, to train surgeons on the SonoSurgery technique. With a view to future growth, Spirecut is developing an AI-powered add-on, supported by the Swiss Innovation Agency (Innosuisse), to enhance real-time nerve tracking during ultrasound-guided procedures. The company has successfully completed a Series A financing round and is preparing for a Series B to scale production and expand its market presence.
Keywords: surgical instruments, MedTech, ultrasound-guided surgery, minimally invasive, carpal tunnel syndrome, trigger finger, percutaneous, hand surgery, orthopedics, Sono-Instruments